References
Reichek N. Magnetic resonance imaging for assessment of myocardial function. Magn Reson Quart 1991; 7(4): 255–274.
Pennell DJ, et al. Magnetic resonance imaging during dobutamine stress in coronary artery disease. Am J Cardiol 1992; 70(1): 34–40.
van Rugge FP, et al. Dobutamine stress magnetic resonance imaging for detection of coronary artery disease. J Am College Cardiol 1993; 22(2): 431–439.
Baer FM, et al. Gradient-echo magnetic resonance imaging during incremental dobutamine infusion for the localization of coronary artery stenoses. Eur Heart J 1994; 15(2): 218–225.
van Rugge FP, et al. Magnetic resonance imaging during dobutamine stress for detection and localization of coronary artery disease. Quantitative wall motion analysis using a modification of the centerline method. Circulation 1994; 90(1): 127–138.
Baer FM, et al. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. Circulation 1995; 91(4): 1006–1015.
Baer FM, et al. Comparison of dobutamine transesophageal echocardiography and dobutamine magnetic resonance imaging for detection of residual myocardial viability. Am J Cardiol 1996; 78(4): 415–419.
Zerhouni EA, et al. Human heart: tagging with MR imaging-a method for noninvasive assessment of myocardial motion. Radiology 1988; 169(1): 59–63.
Axel L, Dougherty L. Heart wall motion: improved method of spatial modulation of magnetization for MR imaging. Radiology 1989; 172(2): 349–350.
Croisille P, et al. Differentiation of viable and nonviable myocardium by the use of three-dimensional tagged MRI in 2-day-old reperfused canine infarcts. Circulation 1999; 99(2): 284–291.
Manning W, et al. First-pass nuclear magnetic resonance imaging studies using gadolinium-DTPA in patients with coronary artery disease. J Am College Cardiol 1991; 18: 959–965.
Wilke N, et al. Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging. Radiology 1997; 204(2): 373–384.
Wilke N, et al. Magnetic resonance first pass myocardial perfusion imaging: clinical validation and future applications. J Magn Reson Imaging 2000
Keijer JT, et al. Semiquantitation of regional myocardial blood flow in normal human subjects by first-pass magnetic resonance imaging. Am Heart J 1995; 130(4): 893–901.
Wilke N, et al. Contrast-enhanced first pass myocardial perfusion imaging: correlation between myocardial blood flow in dogs at rest and during hyperemia. Magn Reson Med 1993; 29(4): 485–497.
Jerosch-Herold M, et al. Magnetic resonance quantification of the myocardial perfusion reserve with a Fermi function model for constrained deconvolution. Med Phys 1998; 25: 73–84.
Gould K, Lipscomb K. Effects of coronary stenosis on coronary flow reserve and resistance. Am J Cardiol 1974; 34: 48–55.
Uren NG, et al. Relation between myocardial blood flow and the severity of coronary-artery stenosis. New England J Med 1994; 330(25): 1782–1788.
Pereira RS, et al. The determination of myocardial viability using Gd-DTPA in a canine model of acute myocardial ischemia and reperfusion. Magn Reson Med 1996; 36(5): 684–693.
Arheden H, et al. Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology 1999; 211(3): 698–708.
Donahue KM, Weisskoff RM, Burstein D. Water diffusion and exchange as they influence contrast enhancement. J Magn Reson Imaging 1997; 7(1): 102–110.
Rogers WJ Jr, et al. Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction [see comments]. Circulation 1999; 99(6): 744–750.
Marchal G, et al. Paramagnetic metalloporphyrins: infarct avid contrast agents for diagnosis of acute myocardial infarction by MRI. Eur Radiol 1996; 6(1): 2–8.
Kim RJ, et al. Fast 23Na magnetic resonance imaging of acute reperfused myocardial infarction. Potential to assess myocardial viability. Circulation 1997; 95(7): 1877–1885.
Yabe T, et al. Quantitative measurements of cardiac phosphorus metabolites in coronary artery disease by 31P magnetic resonance spectroscopy [see comments]. Circulation 1995; 92(1): 15–23.
Straeter-Knowlen IM, et al. 1H NMR spectroscopic imaging of myocardial triglycerides in excised dog hearts subjected to 24 hours of coronary occlusion. Circulation 1996; 93(7): 1464–1470.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stillman, A.E. MR of acquired heart disease: ischemic heart disease. Int J Cardiovasc Imaging 17, 461–465 (2001). https://doi.org/10.1023/A:1020114021586
Issue Date:
DOI: https://doi.org/10.1023/A:1020114021586